Jun Hata Selected Research

Creatinine

3/2023	CKD, Brain Atrophy, and White Matter Lesion Volume: The Japan Prospective Studies Collaboration for Aging and Dementia.
1/2020	Association of Albuminuria With White Matter Hyperintensities Volume on Brain Magnetic Resonance Imaging in Elderly Japanese　- The Hisayama Study.
11/2017	White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.
7/2016	Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese Community　- The Hisayama Study.
1/2013	Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study.
11/2012	Prediction of kidney-related outcomes in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Hata Research Topics

Disease

29	Stroke (Strokes) 01/2021 - 01/2006
21	Ischemic Stroke 04/2019 - 01/2006
18	Dementia (Dementias) 04/2024 - 06/2011
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2009
13	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2008
11	Hypertension (High Blood Pressure) 12/2023 - 01/2006
11	Insulin Resistance 01/2023 - 11/2009
10	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2009
7	Atrophy 03/2024 - 09/2016
7	Diabetes Mellitus 10/2023 - 01/2016
6	Chronic Renal Insufficiency 04/2021 - 10/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022 - 02/2009
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2011
5	Atherosclerosis 03/2020 - 01/2008
5	Stomach Neoplasms (Stomach Cancer) 05/2018 - 04/2009
4	Proteinuria 03/2022 - 09/2004
4	Obesity 01/2022 - 01/2006
4	Prediabetic State (Prediabetes) 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2021 - 07/2003
4	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2014
4	Atrial Fibrillation 01/2021 - 01/2016
4	Infarction (Infarctions) 04/2019 - 02/2009
4	Glucose Intolerance 01/2018 - 09/2010
4	Albuminuria 11/2017 - 11/2012
4	Infections 08/2017 - 04/2009
4	Vascular Diseases (Vascular Disease) 01/2017 - 10/2012
4	Hypercholesterolemia 01/2015 - 09/2004
3	Embolic Stroke 01/2020 - 11/2013
3	Neoplasms (Cancer) 01/2018 - 11/2012
3	Brain Infarction 01/2016 - 03/2007
3	Hemorrhagic Stroke 11/2009 - 01/2006
2	Cognitive Dysfunction 03/2024 - 01/2020
2	Fibrosis (Cirrhosis) 01/2023 - 01/2021
2	Dental Caries (Decay, Dental) 01/2022 - 01/2018
2	Embolism (Embolus) 01/2020 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2018 - 06/2013
2	Masked Hypertension 11/2017 - 06/2013
2	White Coat Hypertension 11/2017 - 06/2013
2	Atrophic Gastritis 12/2016 - 06/2012
2	Carotid Artery Diseases 06/2015 - 06/2013
2	Lacunar Stroke 02/2009 - 02/2007
1	Chronic Pain 12/2023
1	Pain (Aches) 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2023
1	Macular Degeneration (Age-Related Maculopathy) 12/2023

Drug/Important Bio-Agent (IBA)

17	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 12/2009
12	CholesterolIBA 12/2023 - 12/2009
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2013
9	C-Reactive ProteinIBA 01/2024 - 01/2006
9	AlbuminsIBA 03/2023 - 01/2013
9	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2009
7	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 12/2011
7	Antihypertensive Agents (Antihypertensives)IBA 09/2021 - 09/2004
6	CreatinineIBA 03/2023 - 11/2012
6	LDL CholesterolIBA 03/2022 - 02/2009
6	HDL CholesterolIBA 03/2022 - 09/2013
5	ORALIT (ORS)IBA 01/2024 - 01/2013
5	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2016
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2021 - 01/2019
4	Gliclazide (Diamicron)IBA 01/2017 - 10/2012
4	perindopril drug combination indapamideIBA 01/2017 - 10/2012
3	Uric Acid (Urate)IBA 01/2022 - 07/2016
3	ResistinIBA 03/2020 - 11/2009
3	AnticoagulantsIBA 01/2020 - 05/2014
3	Pepsinogen A (Pepsinogen)IBA 05/2018 - 06/2012
3	Angiopoietin-Like Protein 2IBA 01/2016 - 01/2013
3	protein kinase C etaIBA 07/2014 - 02/2007
2	lipopolysaccharide-binding proteinIBA 12/2022 - 11/2019
2	Vitamin A (Retinol)FDA LinkGeneric 01/2022 - 04/2012
2	MagnesiumIBA 01/2022 - 08/2012
2	PotassiumIBA 01/2022 - 08/2012
2	CalciumIBA 01/2022 - 08/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 07/2020
2	Peptides (Polypeptides)IBA 01/2021 - 03/2020
2	Natriuretic PeptidesIBA 01/2021 - 12/2011
2	Glycated Serum AlbuminIBA 10/2020 - 07/2020
2	Arachidonic Acid (Vitamin F)IBA 12/2017 - 12/2013
2	Eicosapentaenoic AcidIBA 12/2017 - 12/2013
2	mahuang-tangIBA 11/2017 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2008
2	1,5-anhydroglucitolIBA 01/2017 - 02/2014
2	ApolipoproteinsIBA 10/2016 - 06/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 12/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 11/2013
2	Angiotensin Receptor AntagonistsIBA 01/2015 - 02/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2014 - 01/2014
2	AdipokinesIBA 09/2014 - 01/2013
2	CytokinesIBA 01/2013 - 01/2008
2	HDL LipoproteinsIBA 10/2010 - 09/2010
2	Protein Kinase CIBA 11/2008 - 02/2007
1	Glial Fibrillary Acidic ProteinIBA 04/2024
1	Amyloid (Amyloid Fibrils)IBA 04/2024
1	GoldIBA 12/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	LipopolysaccharidesIBA 12/2022

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2014
4	Glycemic Control 04/2019 - 10/2011
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2016
2	Thrombolytic Therapy 07/2015 - 10/2014
1	Activities of Daily Living (ADL) 12/2023